Gut Microbes

Article	Citations
Gut microbiota and tuberculosis infection: interaction and therapeutic potential	276
Late-onset sepsis treatment in very preterm infants alters longitudinal microbiome trajectory with lower abundance of Bifidobacterium despite probiotic supplementation	253
The ladder of regulatory stringency and balance: an application to the US FDA’s regulation of bacterial live therapeutics	250
Prolonged oral antimicrobial administration prevents doxorubicin-induced loss of active intestinal stem cells	210
Interactions and substrate selectivity within the SctRST complex of the type III secretion system of enteropathogenic Escherichia coli	206
Akkermansia muciniphila reduces susceptibility to Listeria monocytogenes infection in mice fed a high-fat diet	161
L. rhamnosus CNCM I-3690 survival, adaptation, and small bowel microbiome impact in human	155
3'-Sialyllactose and B. infantis synergistically alleviate gut inflammation and barrier dysfunction by enriching cross-feeding bacteria for short-chain fatty acid biosyn	141
Escherichia coli triggers α-synuclein pathology in the LRRK2 transgenic mouse model of PD	131
Antigenic operon fragmentation and diversification mechanism in Bacteroidota impacts gut metagenomics and pathobionts in Crohn's disease microlesions	127
Opioid-induced dysbiosis of maternal gut microbiota during gestation alters offspring gut microbiota and pain sensitivity	126
Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase	119
Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis	113
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection	110
Modeling spatial interaction networks of the gut microbiota	109
The gut-joint axis mediates the TNF-induced RA process and PBMT therapeutic effects through the metabolites of gut microbiota	108
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome	101
Microbiota during pregnancy and early life: role in maternal−neonatal outcomes based on human evidence	101
A high fiber diet or supplementation with Lactococcus lactis subspecies cremoris to pregnant mice confers protection against intestinal injury in adult offspring	100
Progress of linking gut microbiota and musculoskeletal health: casualty, mechanisms, and translational values	100
Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency	92
Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion	91
Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity	90
Pasteurized Akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice	87
Dietary fiber-based regulation of bile salt hydrolase activity in the gut microbiota and its relevance to human disease	86

Effect of diet on the evolution of gut commensal bacteria	86
Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice	85
Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation	84
Linking serum vitamin D levels with gut microbiota after 1-year lifestyle intervention with Mediterranean diet in patients with obesity and metabolic syndrome: a nested cross-sectional and prospective	84
Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation	83
Intestinal bacteria and colorectal cancer: etiology and treatment	82
Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment	81
Meta-analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression	81
Human milk oligosaccharide metabolism and antibiotic resistance in early gut colonizers: insights from bifidobacteria and lactobacilli in the maternal-infant microbiome	81
Gut microbiota and radiation-induced injury: mechanistic insights and microbial therapies	80
Multi-strain probiotics during pregnancy in women with obesity influence infant gut microbiome development: results from a randomized, double-blind placebo-controlled study	80
Next-generation probiotics – do they open new therapeutic strategies for cancer patients?	79
Therapeutic potential of Clostridium butyricum anticancer effects in colorectal cancer	79
The Fe-S cluster biosynthesis in Enterococcus faecium is essential for anaerobic growth and gastrointestinal colonization	77
The intestinal microbiome of inflammatory bowel disease across the pediatric age range	74
Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review	74
Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice	74
Mucus-penetrating microbiota drive chronic low-grade intestinal inflammation and metabolic dysregulation	74
High throughput genome scale modeling predicts microbial vitamin requirements contribute to gut microbiome community structure	72
The regulatory effect of chitooligosaccharides on islet inflammation in T2D individuals after islet cell transplantation: the mechanism behind Candida albicans abundance	71
In vivo systematic analysis of microbiota-prebiotic crosstalk reveals a synbiotic that effectively ameliorates DSS-induced colitis in mice	71
Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease	71
Antidepressant drugs promote the spread of broad-host-range plasmid in mouse and human gut microbiota	71
Comparison of gnotobiotic communities reveals milk-adapted metabolic functions and unexpected amino acid metabolism by the pre-weaning microbiome	71
Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy	70
Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC	70
Gut microbiota-mediated conversion of mangiferin to norathyriol alters short chain fatty acid and urate metabolism	69
Long COVID and gut microbiome: insights into pathogenesis and therapeutics	68
The crystal structure of the toxin EspC from enteropathogenic Escherichia coli reveals the mechanism that governs host cell entry and cytotoxicity	66
Communication between the gut microbiota and peripheral nervous system in health and chronic disease	64
Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection	64
Maternal milk fat globule membrane enriched gut L. murinus and circulating SCFAs to improve placental efficiency and fetal development in intrauterine growth restricted	64
Gut microbiome diversity, variability, and latent community types compared with shifts in body weight during the freshman year of college in dormitory-housed adolescents	63
Gut microbiota drives structural variation of exogenous probiotics to enhance colonization	63
Gluten-free diet affects fecal small non-coding RNA profiles and microbiome composition in celiac disease supporting a host-gut microbiota crosstalk	61
Citrobacter rodentium possesses a functional type II secretion system necessary for successful host infection	61
MS-20 enhances the gut microbiota-associated antitumor effects of anti-PD1 antibody	61
Acids produced by lactobacilli inhibit the growth of commensal Lachnospiraceae and S24-7 bacteria	61
The microbiota and the host organism switch between cooperation and competition based on dietary iron levels	60
Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease	60
The emerging role of the gut microbiota in vaccination responses	60
Efficacy of fecal microbiota transplantation in patients with Parkinson’s disease: clinical trial results from a randomized, placebo-controlled design	59
Dysbiotic but nonpathogenic shift in the fecal mycobiota of patients with rheumatoid arthritis	59
The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential	58
Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection	58
Akkermansia in the gastrointestinal tract as a modifier of human health	58
Engineered bacteria as an orally administered anti-viral treatment and immunization system	58
Regulation of flagellar motility and biosynthesis in enterohemorrhagic Escherichia coli O157:H7	57
Dietary fiber guar gum-induced shift in gut microbiota metabolism and intestinal immune activity enhances susceptibility to colonic inflammation	57
Gut virome profiling identifies an association between temperate phages and colorectal cancer promoted by Helicobacter pylori infection	57

Entamoeba muris mitigates metabolic consequences of high-fat diet in mice	57
mbSparse: an autoencoder-based imputation method to address sparsity in microbiome data	57
Akkermansia muciniphila upregulates genes involved in maintaining the intestinal barrier function via ADP-heptose-dependent activation of the ALPK1/TIFA pathway	56
Fungal feelings in the irritable bowel syndrome: the intestinal mycobiome and abdominal pain	56
Fecal microbiota transplantation in hematopoietic cell transplant and cellular therapy recipients: lessons learned and the path forward	55
Gut microbiota-mediated C-sulfonate metabolism impairs the bioavailability and anti-cholestatic efficacy of andrographolide	55
Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights	55
Intestinal deguelin drives resistance to acetaminophen-induced hepatotoxicity in female mice	55
Comprehensive assessment of machine learning methods for diagnosing gastrointestinal diseases through whole metagenome sequencing data	54
Sex-specific post-inflammatory dysbiosis mediates chronic visceral pain in colitis	54
Resveratrol amplifies the anti-tumor effect of α-PD-1 by altering the intestinal microbiome and PGD2 content	53
Quorum sensing modulates bacterial virulence and colonization dynamics of the gastrointestinal pathogen Citrobacter rodentium	53
Metagenomic analysis reveals distinct patterns of gut microbiota features with diversified functions in C. difficile infection (CDI), asymptomatic carriage and non-CDI d	53
Secretory IgA dysfunction underlies poor prognosis in Fusobacterium -infected colorectal cancer	53
Clostridioides difficile binary toxin CDT induces biofilm-like persisting microcolonies	51
Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease	51
The transplantation of the gut microbiome of fat-1 mice protects against colonic mucus layer disruption and endoplasmic reticulum stress induced by high fat diet	50
The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation	50
Integrative analysis with microbial modelling and machine learning uncovers potential alleviators for ulcerative colitis	50
Gut microbe–host interactions in post-COVID syndrome: a debilitating or restorative partnership?	50
Why are so many enteric pathogen infections asymptomatic? Pathogen and gut microbiome characteristics associated with diarrhea symptoms and carriage of diarrheagenic E. coli	50
CobB-mediated deacetylation of the chaperone CesA regulates Escherichia coli O157:H7 virulence	49
Alterations in mucosa branched N -glycans lead to dysbiosis and downregulation of ILC3: a key driver of intestinal inflammation	49
Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion	49
Interactions between the gut microbiota and immune cell dynamics: novel insights into the gut-bone axis	48
Human gut-associated Bifidobacterium species salvage exogenous indole, a uremic toxin precursor, to synthesize indole-3-lactic acid via tryptophan	48
Role of gut microbes in acute lung injury/acute respiratory distress syndrome	48
Gut metagenomic characteristics of ADHD reveal low Bacteroides ovatus -associated host cognitive impairment	48
Bacillus coagulans ameliorates inflammatory bone loss in post-menopausal osteoporosis via modulating the “Gut-Immune-Bone” axis	48
The multifaceted virulence of adherent-invasive Escherichia coli	48
Single cell viral tagging of Faecalibacterium prausnitzii reveals rare bacteriophages omitted by other techniques	47
The human gut microbiome and aging	47
CRIg+ macrophages deficiency enhanced inflammation damage in IBD due to gut extracellular vesicles containing microbial DNA	47
Intratumoral microbiome is associated with gastric cancer prognosis and therapy efficacy	47
Long-term yogurt intake and colorectal cancer incidence subclassified by Bifidobacterium abundance in tumor	46
Atovaquone-proguanil and reduced digestive cancer risk: a Toxoplasma gondii connection	46
Multi-omics analysis revealing the interplay between gut microbiome and the host following opioid use	46
Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney disease	46
A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bi	46
Stevioside mitigates metabolic dysregulation in offspring induced by maternal high-fat diet: the role of gut microbiota-driven thermogenesis	46
Gut microbiome at the crossroad of genetic variants and behavior disorders	45
Stability in fecal metabolites amid a diverse gut microbiome composition: a one-month longitudinal study of variability in healthy individuals	45
Human milk oligosaccharides combine with Bifidobacterium longum to form the “golden shield” of the infant intestine: metabolic strategies, health effects, and mechanisms	45
Systemic exposure to bacterial amyloid curli alters the gut mucosal immune response and the microbiome, exacerbating Salmonella -induced arthritis	45
From a hunger-regulating hormone to an antimicrobial peptide: gastrointestinal derived circulating endocrine hormone-peptide YY exerts exocrine antimicrobial effects against selective gut microbiota	45
PMA1-containing extracellular vesicles of Candida albicans triggers immune responses and colitis progression	44
Staphylococcus haemolyticus is a reservoir of antibiotic resistance genes in the preterm infant gut	44
Lactic acid bacteria and bifidobacteria deliberately introduced into the agro-food chain do not significantly increase the antimicrobial resistance gene pool	44
Probiotic-induced enrichment of Adlercreutzia equolifaciens increases gut microbiome wellness index and maps to lower host blood glucose levels	44
Membrane protective role of autophagic machinery during infection of epithelial cells by Candida albicans	43
Pro-mutagenic effects of the gut microbiota in a Lynch syndrome mouse model	43
Epidemiology of bacterial biofilms on polyps and normal tissues in a screening colonoscopy cohort	43
Genome-wide multi-omics analysis reveals the nutrient-dependent metabolic features of mucin-degrading gut bacteria	43
Salmonella utilizes L-arabinose to silence virulence gene expression for accelerated pathogen growth within the host	43
Infant gut microbiota restoration: state of the art	43
Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota	42
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes	42
The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC	42
Exploring substrate–microbe interactions: a metabiotic approach toward developing targeted synbiotic compositions	42
Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms	42
Antibiotic-induced gut dysbiosis elicits gut-brain axis relevant multi-omic signatures and behavioral and neuroendocrine changes in a nonhuman primate model	42
The duodenal mucosa associated microbiome, visceral sensory function, immune activation and psychological comorbidities in functional gastrointestinal disorders with and without self-reported non-celi	42
Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma	42
Predicting butyrate- and propionate-forming bacteria of gut microbiota from sequencing data	41
Stool multi-omics for the study of host–microbe interactions in inflammatory bowel disease	41
A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma	41
Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands	41
PUFAs add fuel to Crohn’s disease-associated AIEC-induced enteritis by exacerbating intestinal epithelial lipid peroxidation	41
Microbiome’s role in musculoskeletal health through the gut-bone axis insights	40
Dietary iron modulates gut microbiota and induces SLPI secretion to promote colorectal tumorigenesis	40
Enterohemorrhagic Escherichia coli responds to gut microbiota metabolites by altering metabolism and activating stress responses	40
Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases	40
Transfer of microbiota from lean donors in combination with prebiotics prevents excessive weight gain and improves gut-brain vagal signaling in obese rats	40
Fusobacterium nucleatum -driven CX3CR1 + PD-L1 + phagocytes route to tumor tissues and reshape tumor microenvir	40
Mouse strain-specific responses along the gut-brain axis upon fecal microbiota transplantation from children with autism	40
Alterations in gut virome are associated with cognitive function and minimal hepatic encephalopathy cross-sectionally and longitudinally in cirrhosis	39
Using a human colonoid-derived monolayer to study bacteriophage translocation	39
End-to-end donor screening and manufacturing controls: complementary quality-based strategies to minimize patient risk for donor-derived microbiome therapeutics	38
Akkermansia muciniphila : a deworming partner independent of type 2 immunity	38
Exploring the etiology of colitis: insights from gut microbiota research	38

Microbiota and mucosal gene expression of fecal microbiota transplantation or placebo treated patients with chronic pouchitis	38
High variation across E. coli hybrid isolates identified in metabolism-related biological pathways co-expressed with virulent genes	38
Paclitaxel chemotherapy disrupts microbiota-enterohepatic bile acid metabolism in mice	37
Single-cell microbiota phenotyping reveals distinct disease and therapy-associated signatures in Crohn’s disease	37
The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention	37
Magnetic chitin beads (MCB) coated with Vibrio cholerae reveals transcriptome dynamics in adult mice with a complex gut microbiota	37
Gut microbiota alterations induced by Roux-en-Y gastric bypass result in glucose-lowering by enhancing intestinal glucose excretion	37
Sweet, bloody consumption – what we eat and how it affects vascular ageing, the BBB and kidney health in CKD	37
IgA-mediated control of host-microbial interaction during weaning reaction influences gut inflammation	37
Oral pathobiont Klebsiella chaperon usher pili provide site-specific adaptation for the inflamed gut mucosa	37
Gut bacterial aromatic amine production: aromatic amino acid decarboxylase and its effects on peripheral serotonin production	37
Gut microbiota-driven metabolic alterations reveal gut–brain communication in Alzheimer’s disease model mice	36
Impact of intensive lifestyle intervention on gut microbiota composition in type 2 diabetes: a post-hoc analysis of a randomized clinical trial	36
Prevotella copri exhausts intrinsic indole-3-pyruvic acid in the host to promote breast cancer progression: inactivation of AMPK via UHRF1-mediated negative regulation	36
The interplay between PCOS pathology and diet on gut microbiota in a mouse model	36
Interaction of the Gut-Liver-Brain Axis and the sterolbiome with sexual dysfunction in patients with cirrhosis	36
The role and mechanism of gut-lung axis mediated bidirectional communication in the occurrence and development of chronic obstructive pulmonary disease	36
Evaluation of gut microbiota predictive potential associated with phenotypic characteristics to identify multifactorial diseases	36
Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunity	35
Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis	35
Rotavirus rewires host cell metabolic pathways toward glutamine catabolism for effective virus infection	35
Parvimonas micra , an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes	35
Fabry disease – a multisystemic disease with gastrointestinal manifestations	35
The Helicobacter pylori cag pathogenicity island as a determinant of gastric cancer risk	35
Integrated analysis of gut metabolome, microbiome, and brain function reveal the role of gut-brain axis in longevity	35
Viral metagenomics of the gut virome of diarrheal children with Rotavirus A infection	35
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis	35
Symbiotic biofilms formed by Clostridioides difficile and bacteroides thetaiotaomicron in the presence of vancomycin	35
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response	35
Quinic acid alleviates high-fat diet-induced neuroinflammation by inhibiting DR3/IKK/NF-κB signaling via gut microbial tryptophan metabolites	35
ZntA maintains zinc and cadmium homeostasis and promotes oxidative stress resistance and virulence in Vibrio parahaemolyticus	35
Gut microbiota-derived 4-hydroxyphenylacetic acid from resveratrol supplementation prevents obesity through SIRT1 signaling activation	35
Reexamining the role of Fusobacterium nucleatum subspecies in clinical and experimental studies	34
Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn’s disease	34
Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst’s FDA approval and implications	34
Morphine mediated neutrophil infiltration in intestinal tissue play essential role in histological damage and microbial dysbiosis	34
The transcriptional regulation of the horizontally acquired iron uptake system, yersiniabactin and its contribution to oxidative stress tolerance and pathogenicity of globally emerging	34
Dietary S. maltophilia induces supersized lipid droplets by enhancing lipogenesis and ER-LD contacts in C. elegans	33
Diet standardization reduces intra-individual microbiome variation	33
Unveiling the hidden players: exploring the role of gut mycobiome in cancer development and treatment dynamics	33
Diet-induced shifts in the gut microbiota influence anastomotic healing in a murine model of colonic surgery	33
Primers matter: Influence of the primer selection on human fungal detection using high throughput sequencing	33
B. longum CKD1 enhances the efficacy of anti-diabetic medicines through upregulation of IL- 22 response in type 2 diabetic mice	33
Neonatal necrotizing enterocolitis: Clostridium butyricum and Clostridium neonatale fermentation metabolism and enteropathogenicity	33
Fecal microbiota transplantation derived from mild cognitive impairment individuals impairs cerebral glucose uptake and cognitive function in wild-type mice: Bacteroidetes	33
Metaproteomics reveals age-specific alterations of gut microbiome in hamsters with SARS-CoV-2 infection	33
Dietary fiber for the prevention of childhood obesity: a focus on the involvement of the gut microbiota	33
Long- and short-term effects of fecal microbiota transplantation on antibiotic resistance genes: results from a randomized placebo-controlled trial	32
M28 family peptidase derived from Peribacillus frigoritolerans initiates trained immunity to prevent MRSA via the complosome-phosphatidylcholine axis	32
A Mediterranean-like fat blend protects against the development of severe colitis in the mucin-2 deficient murine model	32
Psyllium fiber protects mice against western diet-induced metabolic syndrome via the gut microbiota-dependent mechanism	32
Actively replicating gut bacteria identified by 5-ethynyl-2’-deoxyuridine (EdU) click chemistry and cell sorting	32
DSS treatment does not affect murine colonic microbiota in absence of the host	32
Interleukin-1β secretion induced by mucosa-associated gut commensal bacteria promotes intestinal barrier repair	32
Bacteroides fragilis alleviates necrotizing enterocolitis through restoring bile acid metabolism balance using bile salt hydrolase and inhibiting FXR-NLRP3 signaling pathway	32
Breastfeeding and the major fermentation metabolite lactate determine occurrence of Peptostreptococcaceae in infant feces	31
The hidden base of the iceberg: gut peptidoglycome dynamics is foundational to its influence on the host	31
Comparing early life nutritional sources and human milk feeding practices: personalized and dynamic nutrition supports infant gut microbiome development and immune system maturation	31
The microbiota-derived bile acid taurodeoxycholic acid improves hepatic cholesterol levels in mice with cancer cachexia	31
Human microbiota influence the immune cell composition and gene expression in the tumor environment of a murine model of glioma	31
Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions	31
Effect of fecal microbiota transplantation on gut microbiota functional profile in recipients of allogeneic hematopoietic cell transplantation	31
Spatio-temporal dynamics of the human small intestinal microbiome and its response to a synbiotic	31
Fucose promotes intestinal stem cell-mediated intestinal epithelial development through promoting Akkermansia -related propanoate metabolism	31
Effects of postbiotics on chronic diarrhea in young adults: a randomized, double-blind, placebo-controlled crossover trial assessing clinical symptoms, gut microbiota, and metabolite profiles	30
Alcaligenes faecalis promotes colitis to colorectal cancer transition through IgA+ B cell suppression and vinculin acetylation	30
Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project	30
Lactic acid bacteria derived extracellular vesicles: emerging bioactive nanoparticles in modulating host health	30
Maternal-infant probiotic transmission mitigates early-life stress-induced autism in mice	30
Lactobacillus rhamnosus GG ameliorates osteoporosis in ovariectomized rats by regulating the Th17/Treg balance and gut microbiota structure	30
Gut microbiome responds to alteration in female sex hormone status and exacerbates metabolic dysfunction	30
Commensal microbiota-derived metabolite agmatine triggers inflammation to promote colorectal tumorigenesis	30
Gut microbiome in healthy aging versus those associated with frailty	30
The landscape in the gut microbiome of long-lived families reveals new insights on longevity and aging – relevant neural and immune function	30
Better together– Salmonella biofilm-associated antibiotic resistance	30
Muropeptides and muropeptide transporters impact on host immune response	29
Dietary modulation of gut microbiota affects susceptibility to drug-induced liver injury	29
The early life exposome and autism risk: a role for the maternal microbiome?	29
How longitudinal data can contribute to our understanding of host genetic effects on the gut microbiome	29
Diverse but desolate landscape of gut microbial azoreductases: A rationale for idiopathic IBD drug response	29
Microbial bile salt hydrolase activity influences gene expression profiles and gastrointestinal maturation in infant mice	29
Fusobacterium nucleatum promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1/TIFA axis activation	29
Metagenomic source tracking after microbiota transplant therapy	28
Genetic variation in gut microbe as a key regulator of host social behavior in C. elegans	28
Abnormalities in gut virome signatures linked with cognitive impairment in older adults	28
Myeloid-derived suppressor cells prevent disruption of the gut barrier, preserve microbiota composition, and potentiate immunoregulatory pathways in a rat model of experimental autoimmune encephalomye	28
Hydrogen peroxide in breast milk is crucial for gut microbiota formation and myelin development in neonatal mice	28
The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma	27
Effects of Prevotella copri on insulin, gut microbiota and bile acids	27
Preterm infants at low risk for early-onset sepsis differ in early fecal microbiome assembly	27
Parity modulates impact of BMI and gestational weight gain on gut microbiota in human pregnancy	27
Fecal let-7b and miR-21 directly modulate the intestinal microbiota, driving chronic inflammation	27
The human gut serves as a reservoir of hypervirulent Klebsiella pneumoniae	27
New treatment approaches for Clostridioides difficile infections: alternatives to antibiotics and fecal microbiota transplantation	27
Bifidobacterium inhibits the progression of colorectal tumorigenesis in mice through fatty acid isomerization and gut microbiota modulation	27